Litcius/Paper detail

In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score

Jonas Saal, Tobias Bald, M. Hölzel, Manuel Ritter, Peter Brossart, J. Ellinger, N. Klümper

2022Annals of Oncology19 citationsDOI

Topics & Concepts

MedicineRenal cell carcinomaSunitinibSorafenibInternal medicineNephrectomyBevacizumabOncologyClear cell renal cell carcinomaSurgeryHepatocellular carcinomaKidneyChemotherapyRenal cell carcinoma treatmentFerroptosis and cancer prognosisBladder and Urothelial Cancer Treatments
In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score | Litcius